ASX ANNOUNCEMENT 27 October 2026 September 2026 Quarterly Activity Report Melbourne, Australia; 27 October 2026: Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), provides its Quarterly Activity Report for the three-month period ended 30 September 2026. Corporate...
September 2026 Quarterly Activity Report & Appendix 4C
Filed with ASX ·
6ix is reading this filing.
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Prospectus
- Entitlement Offer & Unmarketable Parcel Sale Facility
- Termination of At-the-Market Subscription Deed
- Cynata Receives R&D TI Refund & Repays R&D TI Loan
- R&D Tax Incentive Loan Facility Extension
Later from Cynata Therapeutics
All Cynata Therapeutics news releasesFollow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics